Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: why the tight confidentiality?
The cash will probably be paid over 4-5years so that the J3's can bury payouts with regular profits and thier shareholders won't fine out that they stole our technology.If it was all in one pay out they would be bound by law to advise thier shareholders of a reduced forecast in earnings.
Share
New Message
Please login to post a reply